COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Similar documents
Hadrons on Malignant Cells: Recent Activities within Collaboration between LNS INFN and Vinca Institute of Nuclear Sciences

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Response of Human HTB140 Melanoma Cells to Conventional Radiation and Hadrons

Modelling the induction of cell death and chromosome damage by therapeutic protons

TFY4315 STRÅLINGSBIOFYSIKK

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

III. Proton-therapytherapy. Rome SB - 5/5 1

Recent advances in dosimetry in reference conditions for proton and light-ion beams

Published in: International Journal of Radiation: Oncology - Biology - Physics. Document Version: Peer reviewed version

First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness

Nuclear Data for Radiation Therapy

Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.

Assistant Professor Department of Therapeutic Radiology Yale University School of Medicine

PROGRESS IN HADRONTHERAPY

LET, RBE and Damage to DNA

CHAPTER TWO MECHANISMS OF RADIATION EFFECTS

Biological Optimization of Hadrontherapy. Uwe Oelfke

Radiobiological Characterization of Clinical Proton and Carbon-Ion Beams

Proton and heavy ion radiotherapy: Effect of LET

Radiobiological modelling applied to Unsealed Source (radio) Therapy

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.

Carbon ions of different linear energy transfer (LET) values induce apoptosis & G2 cell cycle arrest in radio-resistant melanoma cells

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Physical Bases : Which Isotopes?

The impact of different radiation qualities on cancer cells

Two-Dimensional Thermoluminescence Dosimetry System for Proton Beam Quality Assurance

Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry

Scoring of linear energy transfer (LET) for calculation of biological dose in proton therapy

What is radiation quality?

Proton and helium beams: the present and the future of light ion beam therapy

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

The ANDANTE project: a multidisciplinary approach to neutron RBE

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

New Treatment Research Facility Project at HIMAC

Interazioni iniziali Radiaz. indirett. ionizzanti (raggi X, raggi γ)

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

ACCELERATORS FOR HADRONTHERAPY

Calculated LET spectrum from antiproton beams stopping in water

Figure 1.1 PHITS geometry for PTB irradiations with: broad beam, upper panel; mono energetic beams, lower panel. Pictures of the setups and of the

Medical Physics 4 I3 Radiation in Medicine

Antiproton induced DNA damage: proton like in flight, carbon-ion like near rest

Impact of variable proton relative biological effectiveness on estimates of secondary cancer risk in paediatric cancer patients Vilde Grandemo

Chapter 14 Basic Radiobiology

Dosimetry and QA of proton and heavier ion beams

Biological Effects of Radiation

Heavy Ion Tumor Therapy

HEAVY PARTICLE THERAPY

Hampton University Proton Therapy Institute

Dependence of the thermoluminescent high-temperature ratio (HTR) of LiF:Mg,Ti detectors on proton energy and dose

Review of Heavy Ion Accelerators for Hadrontherapy

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

Radiation Effects in Life Sciences

DETERMINATION OF DOSE FROM LIGHT CHARGED IONS RELEVANT TO HADRON THERAPY USING THE PARTICLE AND HEAVY ION TRANSPORT SYSTEM (PHITS) A Thesis

Università degli Studi di Napoli Federico II. Dipartimento di Fisica "Ettore Pancini"

Monte Carlo simulation of carbon ion radiotherapy for. Human Eye

Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

PREDICTION OF PROTON AND NEUTRON ABSORBED-DOSE DISTRIBUTIONS IN PROTON BEAM RADIATION THERAPY USING MONTE CARLO N-PARTICLE TRANSPORT CODE (MCNPX)

Introduction to Ion Beam Cancer Therapy

Development and Testing of a Biologic Dosimetric Phantom for Proton and Ion Beam Therapy

ProtonTherapy: A ballistic that will benefit patients? Pr. Xavier Geets MIRO Lab, IREC UCL Radiotherapy Dept. CUSL, Belgium

Commissioning and Radiobiology of the INTRABEAM System

Active Scanning Beam 3 Checking Delivery/Dosimetry

Review of Hadron machines for cancer therapy

The In-flux of Nuclear Science to Radiobiology

BIOLOGICAL EFFECTS OF

Microdosimetric Relative Biological Effectiveness of Therapeutic Proton Beams. Chuan Jong Tung 1,2

Skyscan 1076 in vivo scanning: X-ray dosimetry

A general mechanistic model enables predictions of the biological effectiveness of different qualities of radiation

Cancer situation as presented by (EC 1991)

THERMOLUMINESCENT (TL) DOSIMETRY OF SLOW-NEUTRON FIELDS AT RADIOTHERAPY DOSE LEVEL

C-Beam Induces More Chromosomal Damage In Chemo-Radio-Resistant Cells Than. O-Beam

Design of a BSA for Producing Epithermal Neutron for BNCT

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Basic Press Information

THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

Applications of Particle Accelerators

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

Cell Survival vs Irradiation dose

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Development of Graphite Calorimetry at the NPL for Proton Beam Therapy

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

Radiation Oncology. Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology

Study on Microdosimetry for Boron Neutron Capture Therapy

A comparison of dose distributions measured with two types of radiochromic film dosimeter MD55 and EBT for proton beam of energy 175 MeV

Chapter 7. What is Radiation Biology? Ionizing Radiation. Energy Transfer Determinants 09/21/2014

Medical physics is beautiful

Look! Borg get upgrade already!

LYMHOCYTE CHROMOSOMAL ABERRATION ASSAY IN RADIATION BIODOSIMETRY

5th ADAMAS Workshop at GSI December 15-16, 2016, Darmstadt, Germany

An introduction to medical imaging and radiotherapy: Current status and future directions I

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante

Transcription:

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone b a) Vin a Institute of Nuclear Sciences, Belgrade, Serbia b) INFN Laboratori Nazionali del Sud, Catania, Italy

High ionizing radiation has been commonly used in radiotherapy because of its good radiobiological response in killing malignant growths. A number of studies have investigated the effects of protons and other heavier charged particles on various cell types, most of them being quite radiosensitive. Almost no studies have been done regarding behavior of rather radioresistant cell lines. Present results are a part of an extensive study analyzing radiobiological parameters and viability levels of a resistant melanoma cell line after exposure to conventional and different high ionizing radiation.

Goal Evaluation of physical and radiobiological parameters of the CATANA (Centro di Adro Terapia e Applicazzioni Nucleari Avanzati) proton beam facility, used for the treatment of eye melanoma. Assessment of the effects of two types of proton beams (at the Bragg peak maximum and along the spread-out Bragg peak - SOBP) and a 12 C ion beam (along the Bragg curve), on a resistant human HTB140 melanoma cell line, needed to analyse and predict success of therapeutic irradiations for the limit case. Parameters of analyses: level of cell inactivation, quality of cell inactivation.

Cell culture conditions Irradiation of exponentially growing HTB140 human melanoma cells, Plating efficiency (PE) for HTB140 cells - approximately 70%, Doubling time (Td) for HTB140 cells - 24±2,7 h.

Irradiation conditions Irradiations with 62 MeV/u (superconducting cyclotron at the CATANA treatment facility, INFN, LNS Catania): protons, proton spread out Bragg peak (SOBP), 12 C ions. Irradiation positions were obtained by interposing Perspex plates (PMMA) of different thicknesses in front of cells. Reference dosimetry - plane-parallel PTW 34045 Markus ionization chamber calibrated according to IAEA code of practice (IAEA-TRS-398 2000). Single doses delivered to the cells ranged from 2 to 24 Gy, dose rate - 15 Gy/min. Reference irradiations with 60 Co -rays, at the same dose levels, at average dose rate - 1 Gy/min (Vin a Institute of Nuclear Sciences Belgrade). Particle mean energy ( ) and linear energy transfer (LET) values were obtained by simulations with GEANT4 code.

The CATANA (Centro di Adro Terapia e Applicazzioni Nucleare Avanzati) treatment facility, INFN - LNS, Catania, Italy.

Depth dose distribution in Perspex of the 62 MeV proton beam. 120 Irrad. posit. Perspex (mm) Dose (%) E (MeV) LET (kev/µm) Absorbed Dose (%) 100 80 60 40 20 25.0 90.40±4.00 8.59±0.46 6.90±0.50 0 0 5 10 15 20 25 30 Depth in Perspex (mm)

Depth dose distribution of the spread out Bragg peak in Perspex of the 62 MeV proton beam. 120 B C 100 A Relative dose (%) 80 60 40 Irradiation position A B Depth in Perspex (mm) 6.6 16.3 Dose (%) 87.24±2.61 99.42±0.58 (MeV) 50.90±4.33 34.88±2.15 D 20 C 25.0 102.21±3.43 11.74±1.23 D 26.0 32.12±4.27 5.99±1.36 0 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Depth (mm Perspex)

Depth dose distribution in Perspex of the 62MeV/u 12 C ion beam. 100 B Absorbed Dose (%) 80 60 40 20 Irrad. posit. A B C Perspex (mm ) 6.0 8.8 9.0 Dose (%) 22.04±1.35 92.11±4.76 21.42±6.43 E (MeV) 31.80±3.72 8.97±0.92 4.77±0.65 A LET (kev/µm) 7.50±0.63 22.50±2.84 35.60±4.31 C 0 0 2 4 6 8 10 Depth in Perspex (mm)

Biological assays Cell viability: clonogenic assay (CA). Cell proliferation: incorporation of 5-bromo-2`-deoxyuridine (BrdU) during DNA synthesis.

Radiobiological parameters Surviving fraction (SF2), Relative biological effectiveness (RBE) - inactivation capacity of irradiated cells. RBE(2Gy, γ) is the ratio of 2 Gy γ ray dose and the proton dose generating the same inactivation level as that given by 2 Gy of the reference γ rays. Survival curves best fit by the linear quadratic expression: S = exp ( D D²), S - surviving fraction having dose D, and - free parameters.

1 Dose dependent survival curves after irradiation with 12 C ions (positions A, B and C), protons and -rays. Surviving fraction 0.1 C-ions A C-ions B C-ions C γ-rays protons 0.01 0 5 10 15 20 25 Dose (Gy)

Close to the end of range fluence falls down very fast to zero, while LET rises exponentially, producing the distal declining end of the Bragg curve. Consequently, the decreasing number of particles has leaser hits on irradiated cells. However, these hits by particles with increasing LET cause more irreparable and less reparable lesions. Therefore, there is a relatively higher killing ability of a smaller number of particles when approaching the end of range. This explains why dose dependant survival curves for 12 C ions at irradiation positions B and C are close although there is an important difference in dose levels.

Stronger killing ability of 12 C ions compared to protons is the consequence of their higher LET (22.50 kev/ m vs. 8.97 kev/ m, respectively), while particles mean energy of 12 C ions and protons are quite close (8.97 MeV and 8.59 MeV, respectively). Track structure of the energy deposition, including fragmentation and secondary particles, plays an important role and has to be taken into account when analyzing biological responses to different ion species. Therefore different biological responses are caused by the different track structure for different atomic numbers with similar LET values.

1 Dose dependent surviving fractions after irradiation with protons (SOBP positions A, B, C and D) and -rays. Surviving fraction p - A p - B p - C p - D γ 0.1 0 2 4 6 8 10 12 14 16 18 Dose (Gy)

Radiobiological parameters for different types of radiations Irrad. Irrad. position SF(2 Gy) RBE(2 Gy, ) Irrad. Irrad. position SF(2 Gy) RBE(2 Gy, ) A 0.825±0.061 1.39±0.06 A 0.979 ±0.001 - proton B 0.748±0.103 2.14±0.11 12 C B 0.706±0.114 3.38±0.64 SOBP C 0.562±0.036 4.63±0.23 C 0.576 ±0.092 3.29 ±0.58 D 0.578±0.064 4.26±0.28 Irradiation SF(2 Gy) RBE(2 Gy, ) RBE(8 Gy, ) RBE(12 Gy, ) RBE(16 Gy, ) -rays 0.961±0.004 1 1 1 1 protons 0.931±0.006 1.69±0.17 1.61±0.09 1.64±0.14 1.63±0.13 mid SOBP 0.748±0.103 2.14±0.11 3.16±0.87 3.26±0.79 2.89±0.59 12 C-ions 0.706±0.114 3.38±0.64 3.30±0.39 2.80±0.42 2.47±0.34

Surviving fractions at 2 Gy (SF(2Gy)) are rather high for all irradiations applied, decreasing towards 12 C ions. Relative biological effectiveness (RBE) with respect to -rays at 2 Gy, increases towards 12 C ions. Irregular dose dependence of RBE both for 12 C ions and mid of proton SOBP is caused by different fitting precision. In spite of such high effectiveness of applied irradiation types, these cells remain highly radioresistant with quite low cell inactivation level.

Dose dependant cell proliferation as a function of depth within the proton spread-out Bragg peak, estimated by BrdU assay. Percente of control 100 90 80 70 60 50 40 30 20 10 2 Gy 4 Gy 8 Gy 12 Gy 16 Gy 0 A B C D Irradiation position

Dose dependant cell proliferation as a function of depth within 12 C ion Bragg curve, estimated by BrdU assay. Percentage of control 120 100 80 60 40 20 2 Gy 4 Gy 8 Gy 12 Gy 16 Gy 0 1 A B C Irradiation position

Comparison of proliferation capacities after exposure to different types of irradiation, estimated by BrdU. Percentage of control 100 80 60 40 20 8 Gy 12 Gy 16 Gy 0 gamma rays protons 1 mid proton SOBP 12 C-ions

Proliferation capacity, monitored through ability of irradiated cells to incorporate BrdU, indicates that -rays and unmodulated protons produce, apart from irreparable damages, as shown by corresponding survival curves, also reparable damage to exposed cells, therefore provoking cell cycle arrest and relatively low DNA duplication. Irradiations in the middle of the proton SOBP, because of contributions of higher LET components of superimposed Bragg curves, and particularly close to the Bragg peak maximum of 12 C ions, due to their higher LET, reveal that more irreparable, but less reparable lesions, are induced. This leads to higher level of replication.

Another important concern is the effect of particles at the distal fall off part of the Bragg curve. This is particularly important for hadron therapy planning when a vital healthy tissue is located just behind the treated tumour.

Proliferation capacity estimated after irradiation with 12 C ions (position C) and protons (distal declining end of SOBP). Percentage of control 100 80 60 40 20 8 Gy 12 Gy 16 Gy 0 proton SOBP 12 C-ions

Relatively high values of dose dependant cell proliferation at the distal declining end of proton SOBP and 12 C ions Bragg curve are due to a smaller number of hits to irradiated cells and to a larger number of irreparable lesions induced by these hits. Thus a greater number of cells can maintain active proliferation instead of being involved in complex repair processes. Cell proliferation capacities at the irradiation positions at the distal declining end of the proton SOBP and of 12 C ions (with dose levels of 32.12±4.27 % and 21.42±6.43 %, respectively) are quite close, implying similar levels of irreparable and reparable lesions. Considering that the difference in dose levels is about 10 % and that the degrees of cell proliferation are almost equal, one might expect that for the same dose levels 12 C ions would, due to their higher LET, produce more irreparable and less reparable damages to the cells affected by irradiation, thus reaching higher proliferation level.

CONCLUSION After irradiations with -rays, protons and 12 C ions evaluated radiobiological parameters have shown high resistance of human HTB140 melanoma cells. Due to higher LET, 12 C ions have caused better effectiveness compared to protons. When receiving maximum dose, cells irradiated with -rays or protons, having lower LET, have shown lesser dose dependent proliferation than for 12 C ions. This is correlated to different quality of damage produced in irradiated cells. There is a relatively higher inactivation capacity of protons and 12 C ions on the distal declining end of the Bragg curve compared to the Bragg peak. Reported study, dedicated to the limit of cellular radiosensitivity, reveals how far protons and 12 C ions could reach in producing biological response.